Product Information
OMEPRAZOLE DR 40 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0498 per EA under NDC 57237016250. Its NADAC has been published 260 times since Oct 13, 2021.
FDA first approved this application on Aug 19, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237016250
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203270FDA Approved
8/19/2015
TE Code
AB
On Market Since
8/19/2015
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE DR 40 MG CAPSULE has been published 260 times since Oct 13, 2021, and over the history we have for it it has declined 22.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0498 per EA |
|---|---|
| All-time high | $0.0651 (Nov 10, 2021) |
| All-time low | $0.0430 (Nov 20, 2024) |
| 52-week high | $0.0533 |
| 52-week low | $0.0494 |
| Median price | $0.0539 |
| Average price | $0.0546 |
| Largest weekly change | -21.3% (Nov 20, 2024) |
| Weeks tracked | 260 |
| Tracking since | Oct 13, 2021 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Omeprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEPRAZOLE DR 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE DR 40 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0498 per EA (NDC 57237016250), effective Sep 30, 2026.
How has the price of OMEPRAZOLE DR 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE DR 40 MG CAPSULE has declined 22.9%. It has been tracked across 260 weekly CMS publications since Oct 13, 2021.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE DR 40 MG CAPSULE?
Since Oct 13, 2021, the NADAC for OMEPRAZOLE DR 40 MG CAPSULE has ranged from a low of $0.0430 (Nov 20, 2024) to a high of $0.0651 (Nov 10, 2021), with a median of $0.0539 per EA.
Are there cheaper alternatives to OMEPRAZOLE DR 40 MG CAPSULE?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OMEPRAZOLE DR 40 MG CAPSULE, is $0.0494 per EA — about 1% below OMEPRAZOLE DR 40 MG CAPSULE.
Who manufactures OMEPRAZOLE DR 40 MG CAPSULE?
OMEPRAZOLE DR 40 MG CAPSULE (NDC 57237016250) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.